Policy Impact Analysis - 117/S/4425

Bill Overview

Title: Sickle Cell Care Expansion Act of 2022

Description: This bill establishes programs to increase treatment and other services for populations with sickle cell disease. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke. Specifically, the Department of Health and Human Services (HHS) must award grants to federally qualified health centers, community-based organizations, or other nonprofits that treat or otherwise support populations with sickle cell disease for education and advocacy programs concerning the disease. HHS must also award grants to nonprofits, including hospitals or institutions of higher education, that provide comprehensive care to populations with sickle cell disease for programs to support the transition from pediatric to adult care for patients with the disease. Additionally, the Health Resources and Services Administration must establish a program to provide scholarships or student loan repayment awards to individuals who commit to engage in clinical practice or research related to sickle cell disease for a period of obligated service as physicians.

Sponsors: Sen. Van Hollen, Chris [D-MD]

Target Audience

Population: Individuals with sickle cell disease

Estimated Size: 100000

Reasoning

Simulated Interviews

Nurse (Chicago, IL)

Age: 32 | Gender: female

Wellbeing Before Policy: 5

Duration of Impact: 10.0 years

Commonness: 8/20

Statement of Opinion:

  • The new policy gives me hope that my siblings and people in our community will have better access to specialized services.
  • Continuity from pediatric to adult care is crucial and often neglected. This focus will be a game-changer for many.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 7 5
Year 3 7 4
Year 5 8 4
Year 10 9 3
Year 20 9 3

Advocate (Atlanta, GA)

Age: 45 | Gender: male

Wellbeing Before Policy: 5

Duration of Impact: 10.0 years

Commonness: 9/20

Statement of Opinion:

  • This investment is a critical step in the right direction for our community, but it needs to be sustained and expanded over time.
  • Access to quality healthcare and those trained to manage sickle cell is essential for our children's futures.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 6 5
Year 3 7 5
Year 5 7 4
Year 10 8 4
Year 20 8 3

Graduate Student in Biomedical Sciences (Los Angeles, CA)

Age: 28 | Gender: other

Wellbeing Before Policy: 7

Duration of Impact: 5.0 years

Commonness: 4/20

Statement of Opinion:

  • The policy is a positive step for both patients and researchers.
  • Increased funding could advance research and improve treatment options.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 7 7
Year 2 7 7
Year 3 8 7
Year 5 8 7
Year 10 8 7
Year 20 8 7

College Student (Miami, FL)

Age: 22 | Gender: female

Wellbeing Before Policy: 6

Duration of Impact: 3.0 years

Commonness: 6/20

Statement of Opinion:

  • While I don't have the disease, the improvement in support and awareness impacts my educational and family experiences positively.
  • I hope this promotes more inclusive healthcare practices.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 6
Year 2 7 6
Year 3 7 6
Year 5 7 6
Year 10 7 6
Year 20 7 6

Physician (New York, NY)

Age: 55 | Gender: male

Wellbeing Before Policy: 6

Duration of Impact: 20.0 years

Commonness: 7/20

Statement of Opinion:

  • More funding and educational support are always welcome to improve patient outcomes.
  • Enhancing the transition from pediatric to adult care could reduce hospitalization rates.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 7 6
Year 2 8 6
Year 3 8 6
Year 5 9 5
Year 10 9 5
Year 20 9 4

Community Health Worker (Houston, TX)

Age: 37 | Gender: female

Wellbeing Before Policy: 5

Duration of Impact: 10.0 years

Commonness: 8/20

Statement of Opinion:

  • This is a huge relief as it means the programs I work on can expand and have a greater reach.
  • Education is crucial; people often don’t know about the transition to adult care until it's too late.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 7 5
Year 3 7 5
Year 5 8 4
Year 10 9 4
Year 20 9 3

School Teacher (Detroit, MI)

Age: 30 | Gender: male

Wellbeing Before Policy: 4

Duration of Impact: 20.0 years

Commonness: 7/20

Statement of Opinion:

  • If implemented well, this policy could significantly improve my access to necessary resources, reducing stress and absences from work.
  • The transitional care aspect is particularly important as I have struggled with this myself.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 5 4
Year 2 6 4
Year 3 6 4
Year 5 7 3
Year 10 8 3
Year 20 8 2

Research Scientist (Memphis, TN)

Age: 40 | Gender: female

Wellbeing Before Policy: 7

Duration of Impact: 10.0 years

Commonness: 5/20

Statement of Opinion:

  • The focus on both treatment and research funding is promising.
  • Improved public information campaigns will educate more families about managing the disease.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 7 7
Year 2 8 7
Year 3 8 7
Year 5 8 7
Year 10 9 7
Year 20 9 7

Social Worker (Baltimore, MD)

Age: 50 | Gender: male

Wellbeing Before Policy: 5

Duration of Impact: 15.0 years

Commonness: 6/20

Statement of Opinion:

  • Increased funding will help bridge the gap in care access, particularly in underserved areas.
  • I'm hopeful that the new scholarships will inspire more young professionals to enter this field.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 6 5
Year 3 7 5
Year 5 8 5
Year 10 8 5
Year 20 8 4

Retired (Philadelphia, PA)

Age: 60 | Gender: female

Wellbeing Before Policy: 5

Duration of Impact: 20.0 years

Commonness: 7/20

Statement of Opinion:

  • The resources will ensure my grandson gets better care than past generations received.
  • Transitioning care is critical in managing chronic diseases, and this policy seems to address that well.

Wellbeing Over Time (With vs Without Policy)

Year With Policy Without Policy
Year 1 6 5
Year 2 6 5
Year 3 7 5
Year 5 8 4
Year 10 8 4
Year 20 8 3

Cost Estimates

Year 1: $200000000 (Low: $150000000, High: $250000000)

Year 2: $210000000 (Low: $160000000, High: $260000000)

Year 3: $220000000 (Low: $170000000, High: $270000000)

Year 5: $250000000 (Low: $200000000, High: $300000000)

Year 10: $300000000 (Low: $250000000, High: $350000000)

Year 100: $700000000 (Low: $600000000, High: $800000000)

Key Considerations